Guardion Health Sciences to delist from Nasdaq, dissolve, and liquidate with ~$3.25/share distribution

Guardion Health Sciences, Inc.

Voluntary delisting from Nasdaq effective Oct 21; trading suspended Oct 14; Form 25 filed ~Oct 11.
Certificate of dissolution filed Oct 22; stock transfer books close; no further stock transfers except by will.
Anticipated liquidating dividend of ~$3.25 per share; no assurance on timing or final amount; reserves possible additional distribution.
Mark Goldstone appointed Interim President and CEO effective Oct 18; compensation $7,500/month; replaces Janet Hall.
Company intends to suspend SEC reporting obligations via no-action relief.

item 3.01 item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed (interim)

Mark Goldstone

Interim President and Interim Chief Executive Officer

Guardion Health Sciences, Inc.

Effective: 2024-10-18
Filed: October 3, 2024, 7:59 PM ET

On October 1, 2024, the Company announced the appointment of Mark Goldstone, a member of the Company’s board of directors, to serve as the Company’s Interim President and Interim Chief Executive Officer, effective October 18, 2024.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Mark Goldstone was appointed as Interim President and Interim Chief Executive Officer at Guardion Health Sciences, Inc..

Action: appointed
Role: Interim President and Interim Chief Executive Officer

Exact text from the filing

On October 1, 2024, the Company announced the appointment of Mark Goldstone, a member of the Company’s board of directors, to serve as the Company’s Interim President and Interim Chief Executive Officer, effective October 18, 2024.

View on SEC.gov

Source: SEC EDGAR

accession 0001493152-24-039292

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.